4D Molecular Therapeutics (FDMT) Return on Assets [ROA] (2021 - 2026)
4D Molecular Therapeutics' Return on Assets [ROA] was -35.60% in Q2 2026, up 4.05 percentage points from -39.65% a year earlier but down 5.81 percentage points from the prior quarter.
4D Molecular Therapeutics (FDMT) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at 4D Molecular Therapeutics came in at -24.86%, up 10.87 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of +7.76 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -35.72% in FY2024 (-2.27 pp), -33.46% in FY2023 (+1.47 pp), -34.93% in FY2022 (-12.74 pp) and -22.19% in FY2021 (+10.43 pp).
- Quarterly Return on Assets [ROA] has moved between -46.60% (Q3 2025) and -17.55% (Q2 2024) over five years.
- Compared with a year earlier, Return on Assets [ROA] was higher in four of the last eight quarters, with an average year-over-year change of -5.71 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2024 (a gain of 21.90 percentage points); the worst was Q3 2025 (a drop of 23.17 percentage points).
- Per Business Quant data, FDMT's Return on Assets [ROA] in the three quarters before Q2 2026 was -29.79% (Q1 2026), -28.28% (Q4 2025) and -46.60% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | 4D Molecular Therapeutics | 875.59 Mn | -584.35 Mn | - | -35.60% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.60% |
| Mar 31, 2026 | -29.79% |
| Dec 31, 2025 | -28.28% |
| Sep 30, 2025 | -46.60% |
| Jun 30, 2025 | -39.65% |
| Mar 31, 2025 | -32.79% |
| Dec 31, 2024 | -27.62% |
| Sep 30, 2024 | -23.43% |
| Jun 30, 2024 | -17.55% |
| Mar 31, 2024 | -21.53% |
| Dec 31, 2023 | -28.70% |
| Sep 30, 2023 | -26.82% |
| Jun 30, 2023 | -37.34% |
| Mar 31, 2023 | -43.42% |
| Dec 31, 2022 | -39.65% |
| Sep 30, 2022 | -36.07% |
| Jun 30, 2022 | -32.39% |
| Mar 31, 2022 | -23.93% |
| Dec 31, 2021 | -23.97% |
| Sep 30, 2021 | -26.85% |
4D Molecular Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=FDMT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();